Antibiotice S.A. (BVB:ATB)

Market Cap	1.69B
Revenue (ttm)	669.82M
Net Income (ttm)	87.13M
Shares Out	671.34M
EPS (ttm)	0.13
PE Ratio	19.41
Forward PE	n/a
Dividend	0.02 (0.82%)
Ex-Dividend Date	Sep 25, 2025

Volume	662,315
Average Volume	240,417
Open	2.580
Previous Close	2.610
Day's Range	2.490 - 2.590
52-Week Range	1.750 - 3.440
Beta	0.21
RSI	46.25
Earnings Date	Aug 14, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; and veterinary medicines. Its products are av...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.